Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis

Molecular Therapy

Volumn 21, Issue 7, 2013, Pages 1324-1334

  Dayton, Robert D ^a   Gitcho, Michael A ^b   Orchard, Elysse A ^a   Wilson, Jon D ^c   Wang, David B ^a,e   Cain, Cooper D ^a   Johnson, Jeffrey A ^b   Zhang, Yong Jie ^d   Petrucelli, Leonard ^d   Mathis, J Michael ^a   Klein, Ronald L ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN;

ADENO ASSOCIATED VIRUS; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOPLASM; DEGENERATIVE DISEASE; DISEASE COURSE; FEMALE; GENE MUTATION; GENE TRANSFER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR DYSFUNCTION; NONHUMAN; PATHOGENESIS; PHENOTYPE; RAT; SPINAL CORD; WILD TYPE;

ADENO-ASSOCIATED VIRUS; ANIMALIA; RATTUS; RODENTIA;

EID: 84879687753     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.88     Document Type: Article

References (39)

1. Neumann, M, Sampathu, DM, Kwong, LK, Truax, AC, Micsenyi, MC, Chou, TT et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133. (Pubitemid 44547757)
2. Mackenzie, IR, Bigio, EH, Ince, PG, Geser, F, Neumann, M, Cairns, NJ et al. (2007). Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61: 427-434. (Pubitemid 46878770)
3. Arai, T, Hasegawa, M, Akiyama, H, Ikeda, K, Nonaka, T, Mori, H et al. (2006). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351: 602-611. (Pubitemid 44708852)
4. Arai, T, Mackenzie, IR, Hasegawa, M, Nonoka, T, Niizato, K, Tsuchiya, K et al. (2009). Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 117: 125-136.
5. Igaz, LM, Kwong, LK, Xu, Y, Truax, AC, Uryu, K, Neumann, M et al. (2008). Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol 173: 182-194. (Pubitemid 351947966)
6. Amador-Ortiz, C, Lin, WL, Ahmed, Z, Personett, D, Davies, P, Duara, R et al. (2007). TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61: 435-445. (Pubitemid 46878771)
7. McKee, AC, Gavett, BE, Stern, RA, Nowinski, CJ, Cantu, RC, Kowall, NW et al. (2010). TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 69: 918-929.
8. Wang, DB, Gitcho, MA, Kraemer, BC and Klein, RL (2011). Genetic strategies to study TDP-43 in rodents and to develop preclinical therapeutics for amyotrophic lateral sclerosis. Eur J Neurosci 34: 1179-1188.
9. Winton, MJ, Igaz, LM, Wong, MM, Kwong, LK, Trojanowski, JQ and Lee, VM (2008). Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem 283: 13302-13309.
10. Zhang, YJ, Xu, YF, Cook, C, Gendron, TF, Roettges, P, Link, CD et al. (2009). Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci USA 106: 7607-7612.
11. Barmada, SJ, Skibinski, G, Korb, E, Rao, EJ, Wu, JY and Finkbeiner, S (2010). Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 30: 639-649.
12. Igaz, LM, Kwong, LK, Lee, EB, Chen-Plotkin, A, Swanson, E, Unger, T et al. (2011). Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest 121: 726-738.
13. Miguel, L, Frébourg, T, Campion, D and Lecourtois, M (2011). Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies. Neurobiol Dis 41: 398-406.
14. Wang, DB, Dayton, RD, Henning, PP, Cain, CD, Zhao, LR, Schrott, LM et al. (2010). Expansive gene transfer to the rat CNS and amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed. Mol Ther 18: 2062-2074.
15. Wegorzewska, I, Bell, S, Cairns, NJ, Miller, TM and Baloh, RH (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 106: 18809-18814.
16. Cairns, NJ, Neumann, M, Bigio, EH, Holm, IE, Troost, D, Hatanpaa, KJ et al. (2007). TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171: 227-240. (Pubitemid 47342406)
17. Fuentealba, RA, Udan, M, Bell, S, Wegorzewska, I, Shao, J, Diamond, MI et al. (2010). Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43. J Biol Chem 285: 26304-26314.
18. Budini, M, Buratti, E, Stuani, C, Guarnaccia, C, Romano, V, De Conti, L et al. (2012). Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region. J Biol Chem 287: 7512-7525.
19. Udan, M and Baloh, RH (2011). Implications of the prion-related Q/N domains in TDP-43 and FUS. Prion 5: 1-5.
20. Igaz, LM, Kwong, LK, Chen-Plotkin, A, Winton, MJ, Unger, TL, Xu, Y et al. (2009). Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J Biol Chem 284: 8516-8524.
21. Nonaka, T, Kametani, F, Arai, T, Akiyama, H and Hasegawa, M (2009). Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet 18: 3353-3364.
22. Caccamo, A, Majumder, S, Deng, JJ, Bai, Y, Thornton, FB and Oddo, S (2009). Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neuroflament instability. J Biol Chem 284: 27416-27424.
23. Arai, T, Hasegawa, M, Nonoka, T, Kametani, F, Yamashita, M, Hosokawa, M et al. (2010). Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology 30: 170-181.
24. Foust, KD, Nurre, E, Montgomery, CL, Hernandez, A, Chan, CM and Kaspar, BK (2009). Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27: 59-65.
25. Dayton, RD, Wang, DB and Klein, RL (2012). The advent of AAV9 expands applications for brain and spinal cord gene delivery. Expert Opin Biol Ther 12: 757-766.
26. Klein, RL, Hamby, ME, Gong, Y, Hirko, AC, Wang, S, Hughes, JA et al. (2002). Dose and promoter effects of adeno-associated viral vector for green fuorescent protein expression in the rat brain. Exp Neurol 176: 66-74. (Pubitemid 34762106)
27. Sheean, G (2002). The pathophysiology of spasticity. Eur J Neurol 9 (suppl. 1): 3-9; dicussion 53. (Pubitemid 41759594)
28. Zhang, YJ, Gendron, TF, Xu, YF, Ko, LW, Yen, SH and Petrucelli, L (2010). Phosphorylation regulates proteasomal-mediated degradation and solubility of TAR DNA binding protein-43 C-terminal fragments. Mol Neurodegener 5: 33.
29. Fecto, F and Siddique, T (2012). UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia. Muscle Nerve 45: 157-162.
30. Caccamo, A, Majumder, S and Oddo, S (2012). Cognitive decline typical of frontotemporal lobar degeneration in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43. Am J Pathol 180: 293-302.
31. Harms, MM, Miller, TM and Baloh, RH (2009). TARDBP-related amyotrophic lateral sclerosis. In: Pagon, RA, Bird, TD, Dolan, CR, Stephens, K and Adam, MP (eds). GeneReviews™ [Internet]. University of Washington: Seattle, WA, 1993-2009.
32. Wils, H, Kleinberger, G, Janssens, J, Pereson, S, Joris, G, Cuijt, I et al. (2010). TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 107: 3858-3863.
33. Tatom, JB, Wang, DB, Dayton, RD, Skalli, O, Hutton, ML, Dickson, DW et al. (2009). Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression. Mol Ther 17: 607-613.
34. Haberman, RP, McCown, TJ and Samulski, RJ (1998). Inducible long-term gene expression in brain with adeno-associated virus gene transfer. Gene Ther 5: 1604-1611. (Pubitemid 29008330)
35. Uchida, A, Sasaguri, H, Kimura, N, Tajiri, M, Ohkubo, T, Ono, F et al. (2012). Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. Brain 135(Pt 3): 833-846.
36. McCarty, DM, Monahan, PE and Samulski, RJ (2001). Self-complementary recombinant adeno-associated virus (scAAV) vectors promote effcient transduction independently of DNA synthesis. Gene Ther 8: 1248-1254. (Pubitemid 32780813)
37. Gal, J, Ström, AL, Kilty, R, Zhang, F and Zhu, H (2007). p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J Biol Chem 282: 11068-11077. (Pubitemid 47100749)
38. Gao, G, Vandenberghe, LH, Alvira, MR, Lu, Y, Calcedo, R, Zhou, X et al. (2004). Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol 78: 6381-6388. (Pubitemid 38715936)
39. Dayton, RD, Wang, DB, Cain, CD, Schrott, LM, Ramirez, JJ, King, MA et al. (2012). Frontotemporal lobar degeneration related proteins induce only subtle memory-related defcits when bilaterally overexpressed in the hippocampus. Exp Neurol 224: 197-206.